Actively Recruiting

Age: 0 - 40Years
All Genders
NCT06550102

Drug Response Profiling (DRP) Registry Zurich for Hematological Malignancies

Led by University Children's Hospital, Zurich · Updated on 2024-08-15

1000

Participants Needed

1

Research Sites

521 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

This study is a prospective, non-randomized feasibility study of drug response profiling (DRP) in pediatric blood cancers. Primary cancer cells are isolated from patients and screened ex vivo at single-cell resolution using automated fluorescence microscopy. Drug sensitivity fingerprints are integrated with genetic annotations to inform the treating physician about personalized treatment options. The study aims to determine the practicability of real-time drug response profiling and its actionability in identifying patient-specific cancer dependencies in refractory disease settings.

CONDITIONS

Official Title

Drug Response Profiling (DRP) Registry Zurich for Hematological Malignancies

Who Can Participate

Age: 0 - 40Years
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Pediatric and adult patients below the age of 40 years
  • Diagnosis of hematological malignancy (primary, relapsed or refractory) including leukemia, myeloma or lymphoma
  • Tumor material collected as part of routine diagnostics and willingness to donate tumor material for translational research
  • Patient and/or guardian has signed the informed consent of the DRP registry or of a clinical trial which includes DRP as add-on research.
Not Eligible

You will not qualify if you...

  • Missing informed consent for the registry or of a clinical trial which includes DRP as add-on research

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 1 location

1

University Children's Hospital Zurich

Zurich, Canton of Zurich, Switzerland, 8032

Actively Recruiting

Loading map...

Research Team

J

Jean-Pierre Bourquin, MD, PhD

CONTACT

F

Fabio Steffen, PhD

CONTACT

How is the study designed?

Study Type

OBSERVATIONAL

Masking

N/A

Allocation

N/A

Model

N/A

Primary Purpose

N/A

Number of Arms

1

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here